Sawgrass Asset Management Llc increased Hill Rom Hldgs Inc Com (HRC) stake by 45.21% reported in 2017Q4 SEC filing. Sawgrass Asset Management Llc acquired 6,520 shares as Hill Rom Hldgs Inc Com (HRC)’s stock declined 0.11%. The Sawgrass Asset Management Llc holds 20,940 shares with $1.77M value, up from 14,420 last quarter. Hill Rom Hldgs Inc Com now has $5.95B valuation. The stock decreased 0.08% or $0.07 during the last trading session, reaching $89.75. About 319,368 shares traded. Hill-Rom Holdings, Inc. (NYSE:HRC) has risen 21.27% since May 17, 2017 and is uptrending. It has outperformed by 9.72% the S&P500.
Among 2 analysts covering Premaitha Health Plc (LON:NIPT), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Premaitha Health Plc had 45 analyst reports since September 22, 2015 according to SRatingsIntel. Panmure Gordon maintained Premaitha Health PLC (LON:NIPT) on Wednesday, April 20 with “Buy” rating. As per Tuesday, February 7, the company rating was maintained by FinnCap. The stock has “Buy” rating by Panmure Gordon on Monday, December 14. The firm has “Corporate” rating given on Monday, November 27 by FinnCap. The firm has “Corporate” rating given on Tuesday, May 16 by FinnCap. The stock of Premaitha Health PLC (LON:NIPT) has “Buy” rating given on Wednesday, January 27 by Panmure Gordon. The rating was maintained by Panmure Gordon with “Buy” on Friday, October 2. The stock of Premaitha Health PLC (LON:NIPT) has “Buy” rating given on Wednesday, October 28 by Panmure Gordon. The firm has “Corporate” rating by FinnCap given on Monday, October 31. The company was maintained on Tuesday, May 30 by FinnCap. See Premaitha Health PLC (LON:NIPT) latest ratings:
15/05/2018 Broker: FinnCap Rating: Corporate Old Target: GBX 12.00 Maintain
26/03/2018 Broker: FinnCap Rating: Corporate Maintain
11/12/2017 Broker: FinnCap Rating: Corporate Maintain
27/11/2017 Broker: FinnCap Rating: Corporate Maintain
21/11/2017 Broker: FinnCap Rating: Corporate Maintain
Among 9 analysts covering Hill-Rom (NYSE:HRC), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Hill-Rom had 30 analyst reports since September 23, 2015 according to SRatingsIntel. Barclays Capital maintained it with “Overweight” rating and $90 target in Monday, November 6 report. As per Monday, April 30, the company rating was maintained by Needham. The rating was maintained by Needham on Friday, July 28 with “Buy”. The rating was maintained by Stifel Nicolaus on Sunday, November 26 with “Buy”. KeyBanc Capital Markets maintained Hill-Rom Holdings, Inc. (NYSE:HRC) on Monday, November 6 with “Overweight” rating. The stock has “Buy” rating by Northcoast on Friday, January 12. Morgan Stanley upgraded the shares of HRC in report on Thursday, June 16 to “Overweight” rating. The firm earned “Neutral” rating on Friday, June 30 by Cantor Fitzgerald. Northcoast upgraded the shares of HRC in report on Wednesday, December 16 to “Buy” rating. Stifel Nicolaus maintained it with “Buy” rating and $84 target in Monday, May 1 report.
Since December 11, 2017, it had 0 buys, and 4 insider sales for $19.36 million activity. $8.28 million worth of Hill-Rom Holdings, Inc. (NYSE:HRC) was sold by GREISCH JOHN J. Shares for $82,990 were sold by Johnson Paul Sherwood. Another trade for 7,590 shares valued at $652,892 was made by Rasin Deborah on Thursday, April 12.
Investors sentiment decreased to 0.91 in Q4 2017. Its down 0.25, from 1.16 in 2017Q3. It dived, as 34 investors sold HRC shares while 103 reduced holdings. 46 funds opened positions while 79 raised stakes. 53.30 million shares or 0.86% less from 53.76 million shares in 2017Q3 were reported. Ameritas Ptnrs reported 19,741 shares. Bluemountain Capital Management Limited Liability Com invested in 12,095 shares or 0.02% of the stock. Tiaa Cref Ltd Liability holds 0.01% of its portfolio in Hill-Rom Holdings, Inc. (NYSE:HRC) for 190,321 shares. Cwm Ltd Llc owns 13 shares. South Dakota Invest Council, South Dakota-based fund reported 19,000 shares. Burney owns 5,393 shares for 0.03% of their portfolio. Mirae Asset Invs has 285,438 shares for 0.32% of their portfolio. The California-based Malaga Cove Capital Limited Liability has invested 1.86% in Hill-Rom Holdings, Inc. (NYSE:HRC). Verition Fund Mngmt Ltd Com reported 0.03% of its portfolio in Hill-Rom Holdings, Inc. (NYSE:HRC). Jefferies Limited Com has 0.01% invested in Hill-Rom Holdings, Inc. (NYSE:HRC). Rothschild Asset Management reported 0.66% stake. State Of Tennessee Treasury Department owns 0.02% invested in Hill-Rom Holdings, Inc. (NYSE:HRC) for 40,000 shares. The Ohio-based Meeder Asset has invested 0.03% in Hill-Rom Holdings, Inc. (NYSE:HRC). Cornerstone Hldgs Limited Liability Corp has 0.04% invested in Hill-Rom Holdings, Inc. (NYSE:HRC) for 71,111 shares. Atria Lc holds 3,108 shares.
Sawgrass Asset Management Llc decreased Thor Industries Inc (NYSE:THO) stake by 2,370 shares to 6,405 valued at $965,000 in 2017Q4. It also reduced Dell Technologies Inc Com Cl V stake by 21,608 shares and now owns 79,766 shares. Abbvie Inc. Com (NYSE:ABBV) was reduced too.
More news for Hill-Rom Holdings, Inc. (NYSE:HRC) were recently published by: Prnewswire.com, which released: “Hill-Rom Inaugurates 100000-Square-Foot Welch Allyn Campus Expansion” on May 11, 2018. Streetinsider.com‘s article titled: “Hill-Rom Holdings (HRC) & IMRIS Report Commercial Launch of New Magnetic Resonance Neurosurgical Table” and published on May 01, 2018 is yet another important article.
The stock increased 8.39% or GBX 0.6 during the last trading session, reaching GBX 7.75. About 8.10M shares traded or 1065.33% up from the average. Premaitha Health PLC (LON:NIPT) has 0.00% since May 17, 2017 and is . It has underperformed by 11.55% the S&P500.
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company has market cap of 24.89 million GBP. The firm develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate DownÂ’s syndrome, EdwardÂ’s syndrome, and PatauÂ’s syndrome. It currently has negative earnings. The IONA test is a diagnostic system that enables clinical laboratory clients to perform the test in their own facilities.